| ATPC 0.1157 65.29% | MTEN 0.0323 -8.50% | OCG 0.0098 -16.95% | SOXS 2.065 -9.43% | AUID 2.295 131.23% | CJMB 5.0131 347.60% | IVP 0.0477 -41.83% | ZSL 2.9499 4.61% | SLV 82.9899 -1.86% | NVDA 187.4686 2.36% | SPHL 16.5703 636.46% | INTC 49.117 0.81% | APLT 0.1014 1.50% | BNKK 4.34 56.12% | DVLT 0.7402 3.06% | SOXL 60.9973 10.14% | TQQQ 55.57 3.23% | ASST 0.9927 -3.62% | BYND 1.02 6.04% | TZA 5.905 -4.14% | GRAB 4.41 -4.75% | TSLL 18.3793 1.71% | EEM 58.31 0.97% | ONDS 13.055 -3.72% | BBAI 6.375 1.84% | TSLS 5.145 -0.87% | SPY 694.78 0.64% | IBRX 3.6479 20.79% | MSTX 4.96 -4.62% | NOK 6.725 5.74% | DUST 5.775 -0.43% | AMD 236.295 5.68% | SIDU 3.595 -4.13% | RZLV 4.69 15.52% | BITO 13.39 -1.25% | IBIT 54.725 -1.29% | JTAI 0.4753 4.55% | AAL 15.765 4.13% | NVD 7.065 -4.66% | VALE 14.755 0.99% | QQQ 626.2588 1.08% | PLUG 2.34 -0.43% | SQQQ 64.7999 -3.20% | TSM 349.625 6.88% | XLF 54.585 0.80% | TSLA 443.0155 0.87% | CRWV 98.9301 10.17% | SEGG 1.0905 17.68% | CAN 0.8098 -7.46% | PTHL 0.5285 20.17%

Taylor Morrison Home Corporation (NYSE: TMHC) Surpasses Earnings and Revenue Estimates

Taylor Morrison Home Corporation (NYSE:TMHC) is a leading national land developer and homebuilder, known for its strategic management of inventory, pricing, and sales pace across its communities. Operating in the Zacks Building Products - Home Builders industry, TMHC has consistently outperformed revenue estimates over the past four quarters.

On October 22, 2025, TMHC reported earnings per share (EPS) of $2.01, surpassing the estimated $1.93. This achievement highlights the company's ability to exceed Wall Street expectations. Despite a year-over-year decline in EPS from $2.37, TMHC still delivered a positive surprise of 9.33%, as highlighted by Zacks.

TMHC's revenue for the third quarter of 2025 was $2.1 billion, slightly lower than the previous year's $2.12 billion. However, this figure exceeded the Zacks Consensus Estimate of $2.04 billion, resulting in a positive surprise of 2.76%. This performance underscores the company's resilience in challenging market conditions.

The company's financial health is further supported by a price-to-earnings (P/E) ratio of approximately 6.86, indicating a relatively low valuation compared to its earnings. TMHC's price-to-sales ratio of about 0.73 suggests the market values the company at less than its annual sales, while the enterprise value to sales ratio is approximately 0.97.

TMHC maintains a strong current ratio of approximately 9.43, reflecting its robust ability to cover short-term liabilities with short-term assets. The debt-to-equity ratio of about 0.36 shows a moderate level of debt compared to equity, indicating a balanced financial structure.

Published on: October 22, 2025